Skip to content

Risk of Asthma in Infants With Atopic Dermatitis

Risk of Asthma in Infants With Atopic Dermatitis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00459576
Enrollment
120
Registered
2007-04-12
Start date
2005-05-31
Completion date
2012-12-31
Last updated
2013-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Dermatitis, Atopic, Eczema

Keywords

Asthma, Eczema, Dermatitis, Atopic, Infant

Brief summary

Infants will be enrolled in this study if they have never been diagnosed with asthma or wheezing and have been diagnosed with atopic dermatitis or eczema. Infants with some types of skin rashes are at high risk for developing asthma by 6 years of age. The purpose of this study is to determine whether we can identify infants who will develop asthma.

Detailed description

Asthma is a disease characterized by recurrent episodes of wheezing, inflammation of the airways, and airways that are very sensitive to stimulation (hyper-responsiveness). Symptoms of asthma frequently begin in early childhood; however, it has been difficult to identify pre-symptomatic, at-risk infants and toddlers. Family history of asthma and allergy is strongly associated with the early onset and persistence of asthma symptoms, and children with early onset persistent asthma are more likely to demonstrate allergies. The development of allergic disease results from complex interactions between genetic susceptibility and environmental factors; however, infants with atopic dermatitis have a 50% chance of developing asthma by 6 years of age. Airway inflammation and airway hyper-responsiveness are characteristics of asthmatic children. We plan to evaluate whether infants with allergic dermatitis have evidence of airway inflammation and hyper-responsiveness, and whether cells from the blood and the nose are also hyper-responsive to stimulation prior to the onset of clinical symptoms of asthma. In addition we will evaluate whether certain genetic profiles are associated with allergic disease in infants.

Interventions

None listed

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Indiana University School of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Months to 7 Years
Healthy volunteers
Yes

Inclusion criteria

- 1. Full term infants born greater than 37 weeks 2. History of atopic dermatitis or eczema

Exclusion criteria

1. Heart disease 2. asthma 3. Respiratory illness such as RSV, bronchiolitis or croup 4. Hospitalization for respiratory illness 5. History of wheezing

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026